Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Financing channel feed
After hashing out comeback plans, Deciphera looks to raise $125M from stock sale
3 years ago
Pathalys inks development deal with Abingworth company, raising $150M
3 years ago
Deals
Bluebird hopes to raise upwards of $100M by selling shares
3 years ago
The conference is back. What about the industry? Taking the biotech pulse at #JPM23
3 years ago
In Focus
With CEO search, PhIII study underway, Fulcrum Therapeutics raises $125M from stock offering
3 years ago
R&D
Ready to expand, GenScript raises $224M for CDMO focused on antibodies, cell and gene therapies
3 years ago
China
Outsourcing
Leap Therapeutics jumps into growing Claudin18.2 field by buying Flame Biosciences
3 years ago
Startups
Deals
LinusBio secures Series A for diagnostic platform that uses a single strand of hair
3 years ago
Scoop: Biotech developing oral Alzheimer's drug is on $50M hunt
3 years ago
Startups
Q&A: How to attract the eye of an early investor in biotech R&D tools
3 years ago
Sanofi extends commitment to $750M biotech startup fund
3 years ago
Startups
R&D
Data to dollars: Geron sells stock to raise over $200M after PhIII readout on MDS drug
3 years ago
Updated: Agilent throws down $725M to double manufacturing capacity for nucleic acids to meet API demand
3 years ago
Manufacturing
Scoop: Rakuten billionaire lines up $70M for photoimmunotherapy
3 years ago
Startups
Updated: New Apple Tree biotech emerges with antibodies that might pair with Amgen, Mirati's KRAS drugs
3 years ago
Startups
Amolyt hauls in €130M round to fund PhIII trial of hypoparathyroidism drug
3 years ago
Tumor gene therapy developer rebrands, emerges with $30M from blue-chip investors
3 years ago
Synthekine nabs $100M to boost IL-2 programs after rivals hit setbacks
3 years ago
Startups
Cell/Gene Tx
Updated: Stealth biotech Perceive raises $78M from J&J and Deerfield, says little about eye disease programs
3 years ago
On in vivo cell therapy quest, Takeda-backed Ensoma buys a CRISPR upstart and bags $85M
3 years ago
Deals
Cell/Gene Tx
Amgen kicks off 2023 dealmaking with busy ADC upstart Synaffix
3 years ago
Deals
WuXi inks $1.5B GSK pact, a big biobuck bet but a blip in billions lost from US unverified list
3 years ago
Deals
China
HighTide Therapeutics rides NASH R&D wave with a $107M raise
3 years ago
Startups
China
Sesen Bio pushes back after investor group attacks merger as ‘illogical’
3 years ago
Deals
First page
Previous page
40
41
42
43
44
45
46
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit